Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07691606 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of ARC-02 in B-cell NHL

Name: A Study of ARC-02 in B-cell NHL — clinical trial record (NCT07691606)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ABLATE-101

StatusRecruiting

PhasePhase 1

SponsorTaiho Oncology, Inc.

Started2026-06-22

View on ClinicalTrials.gov ↗

Amendment history

2026-08-25

Study Status, Contacts/Locations v2

Re-verified, no change to tracked fields

2026-07-27

Study Status v1

Start date2026-06-04→2026-06-22

2026-07-08

Original filing

Taiho Oncology, Inc.

17 trials monitored

See 2 trials at risk

Non-Hodgkin Lymphoma

1,512 trials monitored

See 79 trials at risk

This study is to assess safety, tolerability, pharmacokinetics (PK), pharmacodynamic (PD), and preliminary efficacy of ARC-02.

Trial Details

NCT Number	NCT07691606
Lead Sponsor	Taiho Oncology, Inc.
Conditions	B-cell Non Hodgkin Lymphoma
Enrollment	140 participants
Start Date	2026-06-22
Primary Completion	2029-01 (estimated)
Study Completion	2030-12 (estimated)
Updated on ClinicalTrials.gov	2026-08-26